Skip to topic | Skip to bottom

Ús terapèutic del cannabis FICF ©

Fundació Institut Català de Farmacologia

[Darrera revisió: 24 Feb 2011 - 15:03]

Start of topic | Skip to actions

Ús terapèutic del cannabis

Publicacions científiques

  1. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. (Annals Oncology 2011;22 febrer).
  2. Adverse effects of cannabis: inform psychologically vulnerable patients of the risk of serious, dose-dependent disorders. (Prescrire Int 2011;20:28-23).
  3. Bestard JA, Toth CC. An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy. (Pain Pract 2010;18 Novembre).
  4. Parker LA, Rock E, Limebeer C. Regulation of nausea and vomiting by cannabinoids. (Br J Pharmacol 2010;22 Desembre).
  5. Durán M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. (Br J Clin Pharmacol 2010;70:656-663).
  6. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for neuropatic pain: a randomized controlled trial. (CMAJ 2010;340:800-4).
  7. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. (BMJ 2010;340:800-4).
  8. Hoffmann DE, Weber E. Medical marijuana and the law.(N Engl J Med 2010;362:1453-7).
  9. Anònim. Medical Marijuana. The Medical Letter 2010;52:6-7.
  10. Anónimo. New Jersey legalises marijuana for medical use. (BMJ 2010;340:174).
  11. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. (Lancet 2009;374:1383-91).
  12. Anónimo. Dérivés du cannabis et douleur. Une petite place pour le delta9-tétrahydrocannabinol (THC) dans certaines scléroses en plaques. (Prescrire 2009;29:443-6).
  13. Zuurman L, Ippel AE, Moin E, van Gerven JMA. Biomarkers for the effects of cannabis and THC in healthy volunteers. (Br J Clin Pharmacol 2009;67:5-21).
  14. Iversen LL. The Science of Marijuana. (Br J Clin Pharmacol 2009;67:268).
  15. Blakemore C. Classification of cannabis and ecstasy in the UK. (BMJ 2009;338:490-1).
  16. Maldonado R. Cannabis. Beneficio y riesgo. (Med Clin (Barc) 2009;132:625-6).
  17. Rabanal Tornero M, Rams Pla N. Ús terapèutic dels cannabinoides: estudis Seguivex i Seguivex-Emesi. (BIT 2008;20:25-30).
  18. Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a Hampton T. Cannabislike drugs may hold key to treating pain while bypassing the brain. (JAMA 2008;300:1987).
  19. Márquez L, Abanades S, Andreu M. Sistema endocannabinoide e inflamación intestinal. (Med Clin (Barc) 2008;131:513-7).
  20. Anónimo. Patient with multiple sclerosis allowed to grow own cannabis. (BMJ 2008;337:716).
  21. Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. (Can Med Assoc J 2008;178:1669-78).
  22. Madonado R. Sistema endocannabinoide: nuevas perspectivas en el tratamiento global de los factores de riesgo cardiometabólico. (Med Clin (Barc) 2008;130:615-22).
  23. Dyer O. UK tightens rules on cannabis despite advice not do to so. (BMJ 2008;336:1095).
  24. Mukamal KJ, MacLure M, Muller JE, Mittleman LA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. (Am Heart J 2008;155:395-6).
  25. Thompson WM, Poulton R, Broadbent JM, Moffitt TE, Caspi A, Beck JD, Welch D, Hancox RJ. Cannabis smoking and periodontal disease among young adults. (JAMA 2008;299:525-31).
  26. Frank B, Serpell MG, Hughes J, Matthews JNS, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. (BMJ 2008;336:199-201).
  27. Cohen SP. Cannabinoids for chronic pain. (BMJ 2008;336:167-8).
  28. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, Double-Blind,Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients With Intractable Cancer-Related Pain. (J Pain Symptom Manage. 2009 Nov 4).

Copyright © 1999-2019 Fundació Institut Català de Farmacologia.
Comentaris o dubtes sobre aquest espai web? Envia un e-mail.